Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuromuscular Blockade in Pediatric Adenotonsillectomy
NCT06225466Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2024
- Primary completion
- Sep 2024
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rocuronium, Sugammadex in obstructive sleep apnea (OSA), sleep disordered breathing (SDB), sponsored by UT Southwestern Medical Center. Started Apr 2024; status: completed.
02
Drugs
rocuroniumSugammadex
03
Conditions
obstructive sleep apnea (OSA)sleep disordered breathing (SDB)
Beyond the preview
Go deeper on NCT06225466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06225466.